Marginum, a Finnish medical technology company, has reached a major milestone with the announcement that its flagship device, HIVEN®, has been cleared for the CE mark under the European Union’s Medical Device Regulation (MDR). This certification, achieved in just over…
PQE Group is proud to announce that its U.S. subsidiary, PQE US, Inc., has been named the “Best Life Sciences Company in Maryland” by the prestigious Stellar Business Awards. This recognition highlights PQE’s leadership, innovation, and commitment to excellence within…
Teledyne Labtech and Bangor University Pioneer Welsh Space Cooling Project Teledyne Labtech, a global leader in advanced electronic printed circuit board (PCB) solutions, is spearheading an ambitious Welsh-led initiative that could transform the way spacecraft manage heat in the unforgiving…
Pi Health, a global health technology and clinical research company, today announced a strategic collaboration with GSK to deliver fully outsourced clinical research services. The partnership aims to meaningfully improve the speed and efficiency of the clinical trial process. Under…
Summit Therapeutics Inc. announced that data from the Phase III HARMONi-6 trial will be highlighted during the prestigious Presidential Symposium at the upcoming European Society for Medical Oncology (ESMO) Congress 2025, taking place in Berlin, Germany, from October 17–21, 2025.…
Kinea Bio Inc., a biotechnology company dedicated to developing transformative genetic medicines, announced today two major milestones that significantly advance its lead gene therapy program for dysferlinopathy, a rare and debilitating neuromuscular disease. The company has secured a commitment of…
Virtuoso Surgical, Inc., a Nashville-based medical technology company developing a first-of-its-kind class of robotic tools for rigid endoscopic surgery, announced today that its Virtuoso Surgical Robotic System has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).…
Drug Farm, a private biotechnology company pioneering the use of genetics and artificial intelligence to discover and develop innovative immune-modulating therapies, announced today that it has entered into a Material Transfer Agreement (MTA) with Cincinnati Children’s Hospital Medical Center (CCHMC).…
Merck, a leading science and technology company, and Siemens, a global technology leader, have announced the signing of a new Memorandum of Understanding (MoU) that significantly extends their ongoing strategic partnership. The agreement is designed to accelerate digital transformation in…
Exact Sciences Corp., a leader in cancer screening and diagnostic testing, has announced a new awareness campaign in collaboration with actor and horror film icon Matthew Lillard. The initiative aims to motivate adults aged 45 and older to get screened…
Bayer announced significant progress today in its efforts to develop new treatment options for Parkinson’s disease (PD), a chronic and progressive neurodegenerative disorder that affects millions of people worldwide. The company reported two important clinical trial milestones: the initiation of…
Genentech’s Giredestrant Boosts PFS in ER+ Advanced Breast Cancer Genentech, a member of the Roche Group, announced encouraging results from the Phase III evERA study evaluating its investigational oral selective estrogen receptor degrader (SERD), giredestrant, in combination with everolimus. The…